Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-12

Clinical Trial Update: Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating dexpanthenol and hyaluronic acid eye drops for promoting corneal epithelial healing after transepithelial PRK; enrollment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexpanthenol eye drops (dexpanthenol)
  • Hyaluronic acid eye drops (hyaluronic acid)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Corneal Epithelial Wound Healing | Phase 4 | Status: NOT_YET_RECRUITING